A anticovid vaccine to be effective against different variants before boreal autumn “is a possibilitybut not a certainty,” the president of the American pharmaceutical giant declared on Wednesday. PfizerAlbert Bourla.
I hope that by the fall (boreal) – but it is not a certainty – we will be able to have a vaccine that is effective against everything that is known at the moment,” Bourla said during a press conference organized by the International Federation of the Pharmaceutical Industry (IFPMA). ).
Pfizer is carrying out studies to find out what could be the best formula.
Together with the German BioNTech, the pharmaceutical giant developed one of the first vaccines against covid-19, which was injected for the first time in the United Kingdom in late 2020, less than a year after the disease was detected in China.
This messenger RNA vaccine – like Moderna’s – saw reduced efficacy against the Omicron variant of the virus and its subvariants, although it still offers highly effective protection against severe symptoms, hospitalizations and death.
Pfizer is currently testing different vaccines and different doses.
Once we know which is the best path to follow, we will request homologation in the United States, in Europe and in other parts of the world,” he specified.
jrr
–
